12:00 AM
 | 
Jul 23, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Ampligen rintatolimod regulatory update

Hemispherx submitted an NDA to Argentina's National Administration of Drugs, Foods and Medical Technology (ANMAT) for Ampligen to treat chronic fatigue syndrome (CFS). The...

Read the full 99 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >